NRX Pharmaceuticals, Inc. Annual Return On Assets in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2018 to 2023.
  • NRX Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -391 %, a 118% decline year-over-year.
  • NRX Pharmaceuticals, Inc. annual Return On Assets for 2023 was -194 %, a 54.9% decline from 2022.
  • NRX Pharmaceuticals, Inc. annual Return On Assets for 2022 was -126 %, a 65.4% increase from 2021.
  • NRX Pharmaceuticals, Inc. annual Return On Assets for 2021 was -363 %, a 62.3% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -194 -68.9 -54.9% Jan 1, 2023 Dec 31, 2023
2022 -126 +237 +65.4% Jan 1, 2022 Dec 31, 2022
2021 -363 +599 +62.3% Jan 1, 2021 Dec 31, 2021
2020 -962 -963 -115293% Jan 1, 2020 Dec 31, 2020
2019 0.84 +0.74 +783% Jan 1, 2019 Dec 31, 2019
2018 0.09 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.